United States · 
What does Hambrecht & Quist Capital Management invest in?
Hambrecht & Quist Capital Management invests most often at Series C and Series B (65% of the rounds on record), in sectors such as Agriculture and Biopharma.
Hambrecht & Quist Capital Management highlights
- 01
24 rounds on record
- 02
Mostly Series C and Series B: 65% of its rounds
- 03
12 exits from the portfolio
What they do
- Type
- Growth equity (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- AgricultureBiopharma
- Based in
- United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first24 appearances
- 2011
2 rounds
- Mar
- Mar
- 2010
1 round
- Jul
- 2008
1 round
- Jul
- 2007
1 round
- Aug
- 2006
1 round
- Dec
- 2005
1 round
- Oct
- 2004
1 round
- Apr
- 2003
5 rounds
- Dec
- Oct
- Mar
- Jan
- Jan
- 2002
1 round
- Mar
- 2000
2 rounds
- May
- Feb
- 1999
8 rounds
- Dec
- Nov
- Nov
- Nov
- Nov
- Nov
- Oct
- May
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Exits from the portfolio
Companies it backed that were later bought or listed12 in all
Tibion Bionic TechnologiesBought by AlterGUndisclosedJun 2013
ACADIA PharmaceuticalsListed$115MMay 2013
Connected CorporationBought by Iron MountainUndisclosedOct 2012
ShopzillaBought by Symphony Technology Group$165MJun 2011
FlowCardiaBought by C. R. BardUndisclosedMay 2010
Raven BiotechnologiesBought by MacroGenicsUndisclosedJul 2008
Xanthus PharmaceuticalsBought by AntisomaUndisclosedMay 2008
Corus PharmaBought by Gilead SciencesUndisclosedOct 2006
ShopzillaBought by The E.W. Scripps Company$560MJun 2005
XACCT TechnologiesBought by AmdocsUndisclosedFeb 2004
InterPacketBought by Verestar Inc.UndisclosedDec 2001
Paragon SoftwareBought by Unwired PlanetUndisclosedFeb 2000
An exit counts when it came after the firm's first round in the company. From historical deal records.